收稿日期: 2025-12-21
网络出版日期: 2026-06-15
基金资助
国家重点研发计划(2022YFC3601904);天津市卫生健康委员会科技项目(TJWJ2024RC011);天津市天津医院科技基金(TJYYQ2501)
Risk factors analysis and construction of predictive nomogram for acute cerebral infarction in elderly patients with hip fracture
Received date: 2025-12-21
Online published: 2026-06-15
目的 探究老年髋部骨折患者发生急性脑梗死(acute cerebral infarction,ACI)的危险因素并构建风险预测模型。 方法 回顾性选取2023年1月至2025年6月因髋部骨折就诊于天津医院创伤髋关节三科的患者603例,分为训练集(n = 400)和验证集(n = 203)。根据是否发生ACI分为发生组和未发生组,收集患者的临床资料,采用单因素和多因素logistic回顾分析,发现老年髋部骨折患者发生ACI的独立危险因素。基于这些独立危险因素,通过R语言构建列线图预测模型,并评价模型的预测效能。 结果 训练集中纳入的400例老年髋部骨折患者中,有27例患者出现ACI,发生率为6.75%。单因素及多因素logistic分析显示,脑梗死病史、淋巴细胞数、白蛋白、血同型半胱氨酸、胱抑素C、糖化血红蛋白、凝血酶原时间是老年髋部骨折患者合并ACI的独立危险因素(P < 0.05)。基于以上危险因素构建列线图预测模型,受试者工作特征曲线分析显示,训练集和验证集的曲线下面积和95%CI分别为0.896 (0.843 ~ 0.949)、0.830 (0.737 ~ 0.923),预测模型具有较好的区分度。校准曲线显示,预测模型发生与实际发生概率具有较好的一致性。临床决策曲线显示,模型具有较高的临床实用价值。 结论 脑梗死病史、淋巴细胞数、白蛋白、血同型半胱氨酸、胱抑素C、糖化血红蛋白、凝血酶原时间是老年髋部骨折患者发生ACI的独立危险因素,基于7个独立危险因素构建的列线图具有良好的区分度及一致性,有助于临床中在老年髋部骨折患者中识别ACI发生的高危人群。
张亚鑫 , 刘培佳 , 田鹏 , 张志波 , 张文海 , 刘天盛 . 老年髋部骨折患者急性脑梗死的危险因素分析及预测模型构建[J]. 实用医学杂志, 2026 , 42(11) : 1959 -1966 . DOI: 10.3969/j.issn.1006-5725.2026.11.009
Objective To identify independent risk factors for acute cerebral infarction (ACI) in elderly patients with hip fracture and to develop a clinically applicable nomogram for individualized risk prediction. Methods This retrospective study included 603 elderly patients with hip fracture admitted to the Third Department of Traumatic Hip Surgery, Tianjin Hospital, China, between January 2023 and June 2025. Patients were randomly allocated to a training cohort (n = 400) and a validation cohort (n = 203) and categorized based on the occurrence of ACI. Clinical and laboratory variables were collected. Univariate and multivariable logistic regression analyses were performed to identify independent predictors of ACI. A nomogram was constructed using R software based on these predictors, and its performance was evaluated in terms of discrimination, calibration, and clinical utility. Results In the training cohort, 27 of 400 patients (6.75%) developed ACI. Multivariable logistic regression identified seven independent predictors: prior cerebral infarction, lower lymphocyte count, lower albumin level, elevated serum homocysteine, higher cystatin C, elevated glycated hemoglobin (HbA1c), and prolonged prothrombin time (all P < 0.05). The nomogram based on these factors demonstrated excellent discrimination, with an area under the ROC curve (AUC) of 0.896 (95%CI: 0.843 ? 0.949) in the training cohort and 0.830 (95%CI: 0.737 ? 0.923) in the validation cohort. Calibration plots showed good agreement between predicted and observed probabilities of ACI. Decision curve analysis confirmed the model's favorable clinical net benefit across a range of threshold probabilities. Conclusions Prior cerebral infarction, lymphopenia, hypoalbuminemia, hyperhomocysteinemia, elevated cystatin C, higher HbA1c, and prolonged prothrombin time are independent predictors of ACI in elderly hip fracture patients. The developed nomogram exhibits robust discrimination, calibration, and clinical utility, offering a practical tool to facilitate early identification and targeted prevention of ACI in this high-risk population.
Key words: hip fracture; acute cerebral infarction; elderly patients; risk factor; nomogram
| [1] | GONG X, LI X, ZHANG L, et al. Current status and distribution of hip fractures among older adults in China [J]. Osteoporos Int, 2021, 32(9):1785-1793. doi: 10.1007/s00198-021-05849-y . |
| [2] | ZHOU S, SI H, WU L, et al. Association between handgrip strength weakness and asymmetry with incident hip fracture among older Chinese adults [J]. Arch Gerontol Geriatr, 2024, 122:105385. doi: 10.1016/j.archger.2024.105385 . |
| [3] | DE J S, RAVENSBERGEN W, ACHTERBERG W, et al. Initiation of anti-osteoporosis medication following hip fracture in older adults: A systematic review and thematic synthesis of qualitative studies from patient and healthcare professional perspectives [J]. Age Ageing, 2025, 54(8):afaf237. doi: 10.1093/ageing/afaf237 . |
| [4] | 贾燕燕,孙翊嘉,赵迪,等.老年急性进展性脑梗死患者血清磷脂酶A2、S100钙结合蛋白B水平与颈动脉斑块的联系[J].实用医学杂志,2025,41(2):244-249. doi: 10.3969/j.issn.1006-5725.2025.02.014 . |
| [5] | 陈英道,李海宁,李育英,等.血清微小RNA-143-3p、微小RNA-188-5p水平对急性脑梗死患者静脉溶栓后预后不良的预测价值[J].实用医学杂志,2025,41(8):1117-1122. doi: 10.3969/j.issn.1006-5725.2025.08.005 . |
| [6] | MENG Y, LIU Y, FU M, et al. Clinical characteristics of elderly hip fracture patients with chronic cerebrovascular disease and construction of a clinical predictive model for perioperative pneumonia [J]. Orthop Traumatol Surg Res, 2024, 110(3):103821. doi: 10.1016/j.otsr.2024.103821 . |
| [7] | ZHANG Q, WANG M, DU H, et al. Predictive Role of Blood Cell-Derived Inflammatory Markers for the Risk of Asymptomatic Cerebral Infarction in Essential Hypertension: A Population-Based Cross-Sectional Study in Central China [J]. J Inflamm Res, 2025, 18:3523-3534. doi: 10.2147/JIR.S505385 . |
| [8] | 杨波,王建红,余能伟. 急性脑梗死患者血管成功再通前后血清HO-1水平变化及其与患者临床特征的关系[J]. 中华神经医学杂志,2020,19(12):1247-1252. doi:10.3760/cma.j.cn115354-20200519-00378 . |
| [9] | 谷亚伟,楚旭,赵路静,等.小剂量和标准剂量rt-PA静脉溶栓治疗高龄急性缺血性脑卒中的分层研究[J].实用医学杂志,2024,40(11):1568-1573. doi : 10.3969/j.issn.1006-5725.2024. 11.017 . |
| [10] | ALDECOA C, LLAU J, NUVIALS X, et al. Role of albumin in the preservation of endothelial glycocalyx integrity and the microcirculation: A review [J]. Ann Intensive Care, 2020, 10(1):85. doi: 10.1186/s13613-020-00697-1 . |
| [11] | HEYBE M, MEHTA K. Role of albumin infusion in cirrhosis-associated complications [J]. Clin Exp Med,2024, 24(1):58. doi: 10.1007/s10238-024-01315-1 . |
| [12] | ASTAPENKO D, ZRZAVECKY M, GORSKAJA D, et al. Modulation of the capillary leakage by exogenous albumin in a rat model of endothelial glycocalyx damage [J]. Clin Hemorheol Microcirc, 2024, 86(4):509-517. doi: 10.3233/CH-232027 . |
| [13] | PAN S, DU K, LIU S, et al. Albumin adjuvant therapy for acute ischemic stroke with large vessel occlusion (AMASS-LVO): rationale, design, and protocol for a phase 1, open-label, clinical trial [J]. Front Neurol, 2024, 15:1455388. doi: 10.3389/fneur. 2024.1455388 . |
| [14] | ELKIND M, BOEHME A, SMITH C, et al. Infection as a Stroke Risk Factor and Determinant of Outcome After Stroke [J]. Stroke, 2020, 51(10):3156-3168. doi: 10.1161/STROKEAHA. 120.030429 . |
| [15] | CUI L, ZHANG Y, CHEN Z, et al. Early neutrophil count relates to infarct size and fatal outcome after large hemispheric infarction [J]. CNS Neurosci Ther, 2020, 26(8):829-836. doi: 10.1111/cns.13381 . |
| [16] | JOLI C, HERYAMAN H, NAZIR A, et al. The Lymphocyte Depletion in Patients with Acute Ischemic Stroke Associated with Poor Neurologic Outcome [J]. Int J Gen Med, 2021, 14:1843-1851. doi: 10.2147/IJGM.S308325 . |
| [17] | CAI W, LIU S, HU M, et al. Functional Dynamics of Neutrophils After Ischemic Stroke [J]. Transl Stroke Res, 2020, 11(1):108-121. doi: 10.1007/s12975-019-00694-y . |
| [18] | LI Z, LI M, FANG Z, et al. Immunological Mechanisms and Therapeutic Strategies in Cerebral Ischemia-Reperfusion Injury: From Inflammatory Response to Neurorepair [J]. Int J Mol Sci, 2025, 26(17):8336. doi: 10.3390/ijms26178336 . |
| [19] | ZHAI M, CAO S, WANG X, et al. Increased neutrophil-to-lymphocyte ratio is associated with unfavorable functional outcomes in acute pontine infarction [J]. BMC Neurol, 2022, 22(1):445. doi: 10.1186/s12883-022-02969-8 . |
| [20] | DIPROSE W, WANG M, MCFETRIDGE A, et al. Glycated hemoglobin (HbA1c) and outcome following endovascular thrombectomy for ischemic stroke [J]. J Neurointerv Surg, 2020, 12(1):30-32. doi: 10.1136/neurintsurg-2019-015023 . |
| [21] | GUAN H, ZHAO S, FANG X, et al. Frontier technologies for investigating endothelial heterogeneity and function in diabetic vascular disease: An updated review [J]. Biomed Pharmacother, 2025, 191:118445. doi: 10.1016/j.biopha.2025.118445 . |
| [22] | HORTON W, LOVE K, GREGORY J, et al. Metabolic and vascular insulin resistance: Partners in the pathogenesis of cardiovascular disease in diabetes [J]. Am J Physiol Heart Circ Physiol, 2025, 328(6):H1218-H1236. doi: 10.1152/ajpheart. 00826.2024 . |
| [23] | WANG N, ZHANG C. Oxidative Stress: A Culprit in the Progression of Diabetic Kidney Disease [J]. Antioxidants (Basel), 2024, 13(4):455. doi: 10.3390/antiox13040455 . |
| [24] | LI W, SANG H, XU X, et al. The correlation study on homocysteine, blood lipids and blood glucose levels in patients with cerebral infarction [J]. Am J Transl Res, 2021, 13(5):5659-5664. doi: 10.1177/194381412101300509 |
| [25] | MAIDA C, DAIDONE M, PACINELLA G, et al. Diabetes and Ischemic Stroke: An Old and New Relationship an Overview of the Close Interaction between These Diseases [J]. Int J Mol Sci, 2022, 23(4):2397. doi: 10.3390/ijms23042397 . |
| [26] | 宋登花,邓增山,杨晓娟. 急性脑梗死患者动脉僵硬度相关参数变化与神经功能改善的关系[J]. 新医学,2023,54(7):501-505.doi:10.3969/j.issn.0253-9802.2023.07.009 . |
| [27] | GEORGAKIS M, HARSHFIELD E, MALIK R, et al. Diabetes Mellitus, Glycemic Traits, and Cerebrovascular Disease: A Mendelian Randomization Study [J]. Neurology, 2021, 96(13):e1732-e1742. doi: 10.1212/WNL.0000000000011555 . |
| [28] | LAN C, HUANG Z, LUO X, et al. The Correlations Between Serum Hcy Level and Seizures and Cognitive Function in Patients After Stroke [J]. Am J Alzheimers Dis Other Demen, 2022, 37:15333175221146738. doi: 10.1177/15333175221146738 . |
| [29] | JAKUBOWSKI H, WITUCKI ?. Homocysteine Metabolites, Endothelial Dysfunction, and Cardiovascular Disease [J]. Int J Mol Sci, 2025, 26(2):746. doi: 10.3390/ijms26020746 . |
| [30] | HURJUI L, TARNICERIU C, SERBAN D, et al. Homocysteine Attack on Vascular Endothelium-Old and New Features [J]. Int J Mol Sci, 2025, 26(13):6298. doi: 10.3390/ijms26136298 . |
| [31] | SHHARMA D, CHEOK T, ROGERS M, et al. Relationship between homocysteine levels and bone quality in healthy adults- A systematic review and meta-analysis [J]. Clin Nutr ESPEN, 2025, 68:790-805. doi: 10.1016/j.clnesp.2025.06.034 . |
| [32] | MA X, LI Y, LIN X, et al. Development and validation of a predictive model for refracture risk in elderly individuals with osteoporotic vertebral compression fracture: A retrospective study in China [J]. Aging Clin Exp Res, 2025, 37(1):167. doi: 10.1007/s40520-025-03055-y . |
| [33] | ZHANG B, LIU L, XU K, et al. Serum cystatin C as a biomarker to predict all-cause mortality in geriatrics hip fracture [J]. Heliyon, 2024, 10(1):e24037. doi: 10.1016/j.heliyon.2024.e24037 . |
| [34] | YU L, LIU F, ZHANG Q, et al. Sarcopenia index based on serum creatinine and cystatin C is associated with all-cause mortality in patients aged 50 and over with hip fracture [J]. Exp Gerontol, 2025, 204:112750. doi: 10.1016/j.exger.2025.112750 . |
/
| 〈 |
|
〉 |